Ann: Appointment of Director & Medicinal Cannabis Advisory Board, page-4

EV is currently priced less than a shell at around $2m.

I think we'll see earnings start to pick up more this quarter and then into the next as retail spending starts to pick up as everyone goes crazy towards the end of the year.

Also the medicinal cannabis strategy seems to be gaining traction slowly and will soon see confirmation of a binding agreement of some description and the path forward.

These pre ipo investors musnt be the real deal as many I have seen in the same situation pump and support the SP to sell out. These guys are just selling bits and peices when they can like real amateurs.